Brooklyn ImmunoTherapeutics (NYSE:BTX) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report published on Tuesday. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 1.6 % Shares of NYSE:BTX opened at $0.90 on Tuesday. The firm’s 50 day moving average is $1.59 and its two-hundred day moving average […]

Related Keywords

Brooklyn Immunotherapeutics ,Eterna Therapeutics Inc ,Exchange Commission ,Renaissance Technologies ,Brooklyn Immunotherapeutics Company Profile ,Brooklyn Immunotherapeutics Inc ,Free Report ,Get Free Report ,Nyse Btx ,Kbtx ,Information ,Initiated Coverage ,Stocknews Com ,